Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 1
1948 1
1949 1
1950 3
1951 2
1952 1
1953 4
1954 3
1955 6
1956 1
1957 2
1958 2
1959 4
1960 3
1961 4
1962 1
1964 1
1986 1
1989 1
1991 2
1992 2
1995 1
1998 1
2000 1
2002 2
2003 5
2004 6
2005 5
2006 8
2007 8
2008 8
2009 11
2010 11
2011 31
2012 21
2013 20
2014 22
2015 32
2016 34
2017 15
2018 18
2019 22
2020 34
2021 43
2022 36
2023 26
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

439 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
China stroke surveillance report 2021.
Tu WJ, Wang LD; Special Writing Group of China Stroke Surveillance Report. Tu WJ, et al. Mil Med Res. 2023 Jul 19;10(1):33. doi: 10.1186/s40779-023-00463-x. Mil Med Res. 2023. PMID: 37468952 Free PMC article. Review.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric Cancer.
Zhou CB, Pan SY, Jin P, Deng JW, Xue JH, Ma XY, Xie YH, Cao H, Liu Q, Xie WF, Zou XP, Sheng JQ, Wang BM, Wang H, Ren JL, Liu SD, Sun YW, Meng XJ, Zhao G, Chen JX, Cui Y, Wang PQ, Guo HM, Yang L, Chen X, Ding J, Yang XN, Wang XK, Qian AH, Hou LD, Wang Z, Chen YX, Fang JY. Zhou CB, et al. Among authors: pan sy. Gastroenterology. 2022 Jun;162(7):1933-1947.e18. doi: 10.1053/j.gastro.2022.02.015. Epub 2022 Feb 12. Gastroenterology. 2022. PMID: 35167866
Recent updates on bioactive properties of linalool.
An Q, Ren JN, Li X, Fan G, Qu SS, Song Y, Li Y, Pan SY. An Q, et al. Among authors: pan sy. Food Funct. 2021 Nov 1;12(21):10370-10389. doi: 10.1039/d1fo02120f. Food Funct. 2021. PMID: 34611674 Review.
Stem cells and kidney regeneration.
Chou YH, Pan SY, Yang CH, Lin SL. Chou YH, et al. Among authors: pan sy. J Formos Med Assoc. 2014 Apr;113(4):201-9. doi: 10.1016/j.jfma.2013.12.001. Epub 2014 Jan 13. J Formos Med Assoc. 2014. PMID: 24434243 Free article. Review.
439 results